FDA Proposes Major Changes in Food Labels in 2006.

Served as the Assistant General Counsel and director of global regulatory affairs with the Kellogg Company, where he led the development and implementation of the company's global regulatory strategy. He also was chairman of a multidisciplinary team that set policies and global strategies in the areas of health and nutrition claims, fortification, packaging, food safety, FDA compliance.

Miriam Guggenheim is a senior associate at Covington & Burling, practicing in the firm's internationally renowned Food and Drug Group. Her practice focuses primarily on regulation of the food industry, with an emphasis on food labeling, health claims, and other nutrition-related claims and food advertising.  Miriam has extensive experience assisting companies in developing creative messages about the benefits of their products in a manner that furthers their marketing goals while remaining consistent with applicable regulatory requirements. 

Former Vice President and General Counsel of Dole Packaged Foods Company before entering private practice in food law. Instructor:  "Practical Food Law: The Essentials" and "Practical Food Law: Labeling, Advertising and Promotion. " Leslie specializes in food law, with emphasis on food safety, labeling, and ingredient evaluations for conventional foods and dietary supplements, inspections and recalls, biotechnology, organics, advertising,  California 's Proposition 65, continuing food guarantees, and international trade. Writer, Wellness Foods magazine.

Having 12 years of Food & Drug Administration (FDA) experience, she has in-depth knowledge, as an FDA investigator and a compliance officer, of FDA food, drug, medical device (Quality Systems Regulations), radiological health, biologics, cosmetics, Investigational Review Boards (IRBs), clinical investigations, and HACCP requirements.

Benjamin England is a partner in the Miami office of Rodriguez, O'Donnell, Ross, Fuerst, Gonzalez, Williams & England, and P.C.  A 17-year veteran of the U.S. Food and Drug Administration (FDA), Mr. England focuses his practice on FDA matters, including inspections; risk management with special knowledge related to importing FDA regulated products, regulation and agency guidance development; challenging FDA import alerts; export certification for medical devices, drugs, and foods; and all issues related to the development, interpretation, and implementation of FDA's new bioterrorism rules and initiatives.

Mr. Degnan served for eleven years in FDA’s Office of Chief Counsel where he had substantial FDA litigation and enforcement experience as well as serving as the agency’s Associate Chief Counsel for Foods.  He received the agency’s highest awards. At King & Spalding, Mr. Degnan represents several large multinational food companies, a number of domestic drug producers, several international science-based nonprofit associations, and several biotechnology companies.  Mr. Degnan is also the General Counsel of the Food and Drug Law Institute.In December 2004 he was named by the Washingtonian magazine as one of Washington’s “Best” lawyers and included in the magazine’s list of the leading 21 food and drug lawyers.